Page last updated: 2024-10-29

isoxsuprine and Coronary Heart Disease

isoxsuprine has been researched along with Coronary Heart Disease in 2 studies

Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.

Research Excerpts

ExcerptRelevanceReference
" Duration of exposure to tocolysis was at least 30 days (30-180 days) with an oral dosage of 10 mg 3 times daily."1.28Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics. ( Agnetti, A; De Luca, F; Di Pasquale, G; Gemelli, M; Leonardi, R; Mami, C; Manganaro, R; Rando, F, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferri, F1
Petraroli, V1
Gentili, E1
De Paola, D1
Gemelli, M1
De Luca, F1
Manganaro, R1
Leonardi, R1
Rando, F1
Agnetti, A1
Mami, C1
Di Pasquale, G1

Trials

1 trial available for isoxsuprine and Coronary Heart Disease

ArticleYear
[Delayed-action isoxsuprine in the treatment of coronary arteriosclerosis].
    La Clinica terapeutica, 1976, Oct-15, Volume: 79, Issue:1

    Topics: Aged; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Huma

1976

Other Studies

1 other study available for isoxsuprine and Coronary Heart Disease

ArticleYear
Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics.
    European journal of pediatrics, 1990, Volume: 149, Issue:10

    Topics: Adrenergic beta-Agonists; Coronary Disease; Electrocardiography; Female; Fetus; Heart; Humans; Infan

1990